Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
CNS & Neurological Disorders Drug Targets|March 22, 2016
Neuro-Inflammatory Mechanisms in Developmental Disorders Associated with Intellectual Disability and Autism Spectrum Disorder: A Neuro- Immune PerspectiveBarbara Di Marco, Carmela M Bonaccorso, Elisabetta Aloisi, et al.Journal of Anthropological Sciences = Rivista Di Antropologia : JASS|December 22, 2024
Faces from colonial times: the collection of facial casts at the Sapienza University of Rome (Museum of Anthropology "G. Sergi"))Maria Chiara Verducci, Silvia Soncin, Maria Luana Belli, et al.Folia Morphologica|December 8, 2025
Documenting precondylar tubercles and third occipital condyles in human crania from a museological collection (Rome, Italy)Aleksandra Gawlikowska-Sroka, Jacek Szczurowski, Ileana Micarelli, et al.Folia Morphologica|March 13, 2026
Occipitalisation of the atlas: museological case-studies and review of population-based studiesAleksandra Gawlikowska-Sroka, Alba A Bastanza, Ileana Micarelli, et al.Pharmacoeconomics - Open|March 17, 2023
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in ItalyPaolo Angelo Cortesi, Carla Fornari, Paolo Gisondi, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 20, 2017
Potential Involvement of Impaired BKCa Channel Function in Sensory Defensiveness and Some Behavioral Disturbances Induced by Unfamiliar Environment in a Mouse Model of Fragile X SyndromeMaria Isabel Carreno-Munoz, Fabienne Martins, Maria Carmen Medrano, et al.Nature Communications|October 25, 2017
Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout miceElisabetta Aloisi, Katy Le Corf, Julien Dupuis, et al.Acta Dermato-Venereologica|December 3, 2020
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME StudyMarina Talamonti, Giovanna Malara, Ylenia Natalini, et al.Clinical, Cosmetic and Investigational Dermatology|January 13, 2023
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME StudyLuca Stingeni, Giovanna Malara, Andrea Conti, et al.Clinical, Cosmetic and Investigational Dermatology|April 10, 2023
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME StudyMarina Talamonti, Filomena Russo, Giovanna Malara, et al.Pageof 2